Mirivadelgat

· Foresee Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mirivadelgat, covering 2025-10-06 to 2025-10-06. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD [Phase 2]